• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Restrictive Blood Transfusion Policies are Associated with a Lower Risk of Infection

April 9, 2014

A recent study published in JAMA adds support for the growing body of evidence recommending a restrictive red blood cell (RBC) transfusion strategy.

Rohde et al. performed a meta-analysis comparing hospital-acquired infections from 7,500 patients enrolled in 18 randomized trials.  They found rates of hospital-acquired infections were 16.9% in the liberal transfusion group and 11.8% in the conservative transfusion group (risk ratio = 0.82; 95% CI, 0.72-0.95).  When the restrictive transfusion threshold was set at less than 7.0 g/dL, the number needed to treat was 20, indicating that one patient could potentially avoid an infection out of every 20 patients treated.  The reduced risk of infection remained even among individuals who received leukocyte reduced RBCs.  More studies are needed to determine the optimal threshold for restrictive RBC transfusion strategies.

References

1. Carson JL. Blood transfusion and risk of infection: new convincing evidence. JAMA : the journal of the American Medical Association 2014; 311(13): 1293-4.

2. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA : the journal of the American Medical Association 2014; 311(13): 1317-26.

Filed Under

  • News
  • RBC Transfusion

Recommended

  • Guidelines for Hemolytic Disease of the Newborn

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Donor Lymphocytes May Play a Large Role in Transfusion-Associated Graft-Versus-Host Disease

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

  • Caffeine in Donor Blood Reduces Quality of Stored RBCs

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley